Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.
Episteme Prognostics has raised $4.1M in total funding. The most recent round was Seed. The last funding was announced in April 2023.
Episteme Prognostics is headquartered in New York, United States.
Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.
Episteme Prognostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Episteme Prognostics — Funding & Investors." VCBacked, April 13, 2023, https://www.vcbacked.co/company/episteme-prognostics. Accessed August 13, 2026.
VCBacked. (2023). Episteme Prognostics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/episteme-prognostics
{{cite web |title=Episteme Prognostics — Funding & Investors |url=https://www.vcbacked.co/company/episteme-prognostics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated